Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-14

Clinical Trial Update: Does Sevoflurane Cause Genomic Damage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating whether sevoflurane exposure causes genomic damage, sponsored by Jubilee Mission Medical College and Research Institute, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Jubilee Mission Medical College and Research Institute | Conditions: Anesthesia; Adverse Effect | Phase 4 | Status: UNKNOWN